A detailed history of Redmile Group, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Redmile Group, LLC holds 5,453,083 shares of SRRK stock, worth $43.8 Million. This represents 2.96% of its overall portfolio holdings.

Number of Shares
5,453,083
Previous 6,419,610 15.06%
Holding current value
$43.8 Million
Previous $114 Million 60.16%
% of portfolio
2.96%
Previous 4.49%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $7.58 Million - $16.2 Million
-966,527 Reduced 15.06%
5,453,083 $45.4 Million
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $225,786 - $303,784
17,105 Added 0.27%
6,419,610 $114 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $13 Million - $40.6 Million
1,998,665 Added 45.38%
6,402,505 $120 Million
Q2 2023

Aug 14, 2023

BUY
$5.79 - $9.11 $7.41 Million - $11.7 Million
1,279,614 Added 40.96%
4,403,840 $33.2 Million
Q1 2023

May 15, 2023

BUY
$7.36 - $12.72 $7.57 Million - $13.1 Million
1,028,406 Added 49.07%
3,124,226 $25 Million
Q4 2022

Feb 14, 2023

SELL
$7.02 - $9.76 $7.33 Million - $10.2 Million
-1,044,206 Reduced 33.25%
2,095,820 $19 Million
Q3 2022

Nov 14, 2022

SELL
$5.33 - $11.3 $1.41 Million - $2.98 Million
-263,900 Reduced 7.75%
3,140,026 $21.8 Million
Q2 2022

Aug 15, 2022

BUY
$4.66 - $13.96 $4.64 Million - $13.9 Million
996,600 Added 41.4%
3,403,926 $18.7 Million
Q1 2022

May 16, 2022

SELL
$11.89 - $24.68 $482,734 - $1 Million
-40,600 Reduced 1.66%
2,407,326 $31 Million
Q4 2021

Feb 14, 2022

SELL
$24.14 - $35.18 $2.47 Million - $3.6 Million
-102,279 Reduced 4.01%
2,447,926 $60.8 Million
Q3 2021

Nov 15, 2021

BUY
$27.38 - $42.21 $6.66 Million - $10.3 Million
243,177 Added 10.54%
2,550,205 $84.2 Million
Q2 2021

Aug 16, 2021

BUY
$26.34 - $46.62 $3.43 Million - $6.08 Million
130,400 Added 5.99%
2,307,028 $66.7 Million
Q1 2021

May 17, 2021

SELL
$45.96 - $68.02 $33.1 Million - $49 Million
-719,961 Reduced 24.86%
2,176,628 $110 Million
Q4 2020

Feb 16, 2021

SELL
$13.72 - $51.57 $58,996 - $221,751
-4,300 Reduced 0.15%
2,896,589 $141 Million
Q3 2020

Nov 16, 2020

BUY
$10.54 - $18.47 $263,500 - $461,750
25,000 Added 0.87%
2,900,889 $51.3 Million
Q2 2020

Aug 14, 2020

SELL
$10.37 - $20.64 $147,254 - $293,088
-14,200 Reduced 0.49%
2,875,889 $52.4 Million
Q1 2020

May 15, 2020

SELL
$9.63 - $17.14 $489,204 - $870,712
-50,800 Reduced 1.73%
2,890,089 $35 Million
Q4 2019

Feb 14, 2020

BUY
$7.2 - $13.2 $601,200 - $1.1 Million
83,500 Added 2.92%
2,940,889 $38.8 Million
Q3 2019

Nov 14, 2019

SELL
$8.95 - $15.72 $563,850 - $990,360
-63,000 Reduced 2.16%
2,857,389 $25.6 Million
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $12.7 Million - $19.5 Million
869,300 Added 42.38%
2,920,389 $46.3 Million
Q1 2019

May 15, 2019

BUY
$14.24 - $22.28 $4.13 Million - $6.45 Million
289,682 Added 16.45%
2,051,089 $38.5 Million
Q4 2018

Feb 14, 2019

SELL
$17.86 - $28.77 $208,962 - $336,609
-11,700 Reduced 0.66%
1,761,407 $40.5 Million
Q3 2018

Nov 14, 2018

BUY
$13.39 - $26.25 $303,939 - $595,848
22,699 Added 1.3%
1,773,107 $45.7 Million
Q2 2018

Aug 14, 2018

BUY
$15.0 - $25.6 $26.3 Million - $44.8 Million
1,750,408 New
1,750,408 $27.3 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $415M
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.